ATP5MK and schizophrenia: Although there is a schizophrenia risk eQTL SNPs in E2 (rs2297787, GWAS P = 1.5e-13, eQTL P = 7e-06; Supplementary Fig. 11) region that correlated with ATP5MD expression, we didn’t observe genotypic effect on the ATP5MD promoter activity in luciferase reporter assay (Fig. 3a, right).